Skip to content

Comparison of Individual Computer Aided Design/Manufactured (CAD/CAM) - Based Implants Consisting on Hydroxylapatite and Titanium to be Used in Cranioplasty

Comparison of Individual CAD/CAM-based Implants Consisting on Hydroxylapatite and Titanium to be Used in Cranioplasty - a Randomized Multicenter Clinical Trial

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00923793
Enrollment
53
Registered
2009-06-18
Start date
2009-06-30
Completion date
2014-04-30
Last updated
2015-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cranioplasty, Skull Defects

Keywords

skull defects, Hydroxylapatite implant, Titanium implant, calotte defects without the possibility to be covered with the missing own bone

Brief summary

The purpose of this study is to compare the results of cranioplasty with CAD/CAM (computer aided design/manufactured) based Hydroxylapatite and Titanium implants in respect to infections, re-operations, antibiotic treatment or removal of the implant.

Detailed description

Both implant materials for cranioplasty, Hydroxylapatite and Titanium, are CE certified medical devices used in common practices. This study is intended to get prospective data in addition to the empirical and retrospective existing ones to enable the decision on which implant material should be preferably employed in future.

Interventions

DEVICETitanium implant (CranioConstruct™)

One to three weeks before operation the skull defect is well defined using Computer tomography. Based on these results the Titanium implant is ordered.

DEVICEHydroxylapatite (CustomBone)

Six to eight weeks before operation the skull defect is well defined using Computer tomography. Based on these results the Hydroxylapatite implant is ordered.

Sponsors

Universitätsklinikum Leipzig
CollaboratorOTHER
University of Leipzig
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Skull defects without the possibility to be covered with the missing own bone 2. Size of the defect ≥ 16 cm2 3. Age ≥ 18 4. Written informed consent of the patient

Exclusion criteria

1. Active tumor 2. ASA 4 classification 3. Allergic disposition to ceramic or titanium 4. Concomitant participation in other clinical trials 5. Pregnant or nursing women 6. Expected low compliance 7. HIV positive 8. Active drug abuses

Design outcomes

Primary

MeasureTime frame
Comparison of the rate of local and/or systemic infections (acute/chronic) in both study arms within the first 6 months after operation.6 months

Secondary

MeasureTime frame
Comparison of the rate of re-operations with and without ex-plantation of the implant in both arms.6 months
Comparison of post-operative computer tomography (CT) (native and bone 5 mm) within 48 h in respect to bleeding, dislocation and further complications after cranioplasty in both arms.48 hours post-operative
Comparison between both groups referring to cosmetic result, period of hospitalization, costs, intra-operative features.6 months
Comparison of temperature sensitivity (cold/heat) six months after implantation in both groups.6 months
Description of osteointegration with CT and bone scan six months post-operative in both groups6 months
Comparison of health-related quality of life after cranioplasty in both arms using the SF36-questionnaire.6 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026